KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

Shuji Ogino*, Jeffrey A. Meyerhardt, Natsumi Irahara, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

177 Scopus citations

Fingerprint

Dive into the research topics of 'KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science